喉頭がん治療薬の世界市場レポート 2024

喉頭がん治療薬の市場規模は、今後数年間で大幅な成長が見込まれています。2028年には6.1%の年間複合成長率（CAGR）で38億8,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、標的療法と免疫療法の進歩、ゲノム医療の統合、高齢者人口の増加、健康への取り組みにおける世界の協力、がん治療における遠隔医療の役割の拡大に起因すると考えられます。予測期間中に予想される注目すべき動向には、医学調査の継続的な進歩、免疫療法の継続的な進歩、個別化医療とバイオマーカーの開発と応用、併用療法の探索、患者中心のケアの重視、がん治療に対するヘルスケア政策と医療へのアクセスの進化が含まれます。

タバコの普及率の増加により、将来、喉頭がん治療薬市場の成長が促進されると予想されます。タバコはニコチアナ属の植物の葉に由来し、吸う、噛む、嗅ぐなどさまざまな形で利用されます。喉頭がんの主要な危険因子として、タバコの使用は病気の発症と治療結果に大きな影響を与えます。喉頭がん治療薬は、タバコの使用が症状とその全体的な管理に及ぼす影響に対処することに重点を置いています。特に、カナダ統計局は、2022年7月の紙巻きタバコ生産量が2021年6月と比較して5.8％増加し、紙巻きタバコの総販売数は2022年6月に1.3％増加して14億本に達したと報告しました。これは、喉頭がん治療薬市場の成長を促進する上でタバコ普及率の増加が果たす役割を強調しています。

化学療法に対する需要の高まりは、今後数年間で喉頭がん治療薬市場の主要な促進要因となる見込みです。がんを治療するために薬物を使用する化学療法は、進行期の喉頭がんを管理するためにますます求められています。喉頭の一部を保存し、がん細胞の増殖を制御し、症状を軽減し、患者の全体的な生活の質を向上させるのに効果的であることが証明されています。米国がん協会の2022年1月のデータによれば、米国のがん生存者数は1,806万100人と推定されており、化学療法に対する需要の高まりは、喉頭がん治療薬市場における化学療法の重要性を浮き彫りにしています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の喉頭がん治療薬市場の促進要因と抑制要因
  • 市場の促進要因
  • 市場の抑制要因
• 世界の喉頭がん治療薬市場規模実績と成長、2018年～2023年
• 世界の喉頭がん治療薬市場規模と成長予測、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の喉頭がん治療薬市場、治療タイプ別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
• 化学療法
• 免疫療法
• その他の治療法
• 世界の喉頭がん治療薬市場、投与経路別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
• 経口
• 非経口
• 世界の喉頭がん治療薬市場、流通チャネル別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
• 病院薬局
• オンライン薬局
• 小売薬局
• 世界の喉頭がん治療薬市場、エンドユーザー別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
• 病院
• ホームケア
• 専門センター
• その他のエンドユーザー

第7章 地域と国の分析

• 世界の喉頭がん治療薬市場、地域別、実績と予測、2018年～2023年、2023年～2028年、2033年
• 世界の喉頭がん治療薬市場、国別、実績と予測、2018年～2023年、2023年～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 喉頭がん治療薬市場の競合情勢
• 喉頭がん治療薬市場の企業プロファイル
  • Pfizer Inc.
  • F. Hoffmann La Roche Ltd.
  • Merck &Co.
  • AbbVie Inc.
  • Novartis AG

第31章 その他の大手と革新的な企業

• Bayer AG
• Sanofi-Aventis LLC
• Bristol Myers Squibb
• AstraZeneca plc
• Abbott Laboratories
• GlaxoSmithKline plc
• Eli Lilly and Company
• Amgen Inc.
• CH Boehringer Sohn AG &Co. KG.
• Regeneron Pharmaceuticals Inc.
• Incyte Corporation
• Aurobindo Pharma Ltd.
• Cipla Inc.
• Hikma Pharmaceuticals plc
• Amneal Pharmaceuticals LLC

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Laryngeal cancer therapeutics encompass various treatments and therapeutic approaches employed to manage laryngeal cancer, a type of cancer that originates in the tissues of the larynx (voice box). The selection of treatment modalities is influenced by factors such as the stage and location of the cancer, overall health, and individual preferences.

The primary treatment types for laryngeal cancer therapeutics include chemotherapy, immunotherapy, and others. Chemotherapy involves the use of potent drugs to kill or inhibit the growth of rapidly dividing cells, including cancer cells. In the context of laryngeal cancer, chemotherapy is often utilized to shrink cancerous cells before surgical intervention. The administration routes for chemotherapy drugs include oral and parenteral, and these drugs are distributed through hospital pharmacies, online pharmacies, and retail pharmacies. End users of laryngeal cancer therapeutics include hospitals, homecare, specialty centers, and others.

The laryngeal cancer therapeutics market research report is one of a series of new reports from The Business Research Company that provides laryngeal cancer therapeutics market statistics, including laryngeal cancer therapeutics industry global market size, regional shares, competitors with a laryngeal cancer therapeutics market share, detailed laryngeal cancer therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the laryngeal cancer therapeutics industry. This laryngeal cancer therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The laryngeal cancer therapeutics market size has grown strongly in recent years. It will grow from $2.86 billion in 2023 to $3.06 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. The growth observed in the historical period can be attributed to several factors, including the increasing incidence of laryngeal cancer, the evolution of treatment modalities, active engagement in clinical trial activities, government initiatives and funding directed towards cancer research and treatment, and enhanced patient awareness and education.

The laryngeal cancer therapeutics market size is expected to see strong growth in the next few years. It will grow to $3.88 billion in 2028 at a compound annual growth rate (CAGR) of 6.1%. The anticipated growth in the forecast period can be attributed to advancements in targeted and immunotherapy, the integration of genomic medicine, a growing geriatric population, global collaborations in health initiatives, and the expanding role of telemedicine in cancer care. Noteworthy trends expected in the forecast period include continued advancements in medical research, ongoing progress in immunotherapy, the development and application of personalized medicine and biomarkers, the exploration of combination therapies, an emphasis on patient-centric care, and evolving healthcare policies and access to cancer treatments.

The increasing prevalence of tobacco is anticipated to drive the growth of the laryngeal cancer therapeutics market in the future. Tobacco, derived from the leaves of Nicotiana plants, is utilized in various forms such as smoking, chewing, and snuffing. As a major risk factor for laryngeal cancer, tobacco use significantly influences the development and treatment outcomes of the disease. Laryngeal cancer therapeutics are focused on addressing the impact of tobacco use on the condition and its overall management. Notably, Statistics Canada reported a 5.8% increase in cigarette production in July 2022 compared to June 2021, with the total number of cigarettes sold rising by 1.3% in June 2022 to reach 1.4 billion. This underscores the role of increased tobacco prevalence in propelling the growth of the laryngeal cancer therapeutics market.

The rising demand for chemotherapy is poised to be a key driver for the laryngeal cancer therapeutics market in the coming years. Chemotherapy, involving the use of drugs to treat cancer, is increasingly sought after for managing advanced-stage laryngeal cancer. It proves effective in preserving parts of the larynx, controlling cancer cell growth, alleviating symptoms, and enhancing patients' overall quality of life. As per the American Cancer Society's data from January 2022, which estimated the number of U.S. cancer survivors at 18,060,100, the growing demand for chemotherapy underscores its significance in the laryngeal cancer therapeutics market.

The high cost of cancer treatment is expected to pose a hindrance to the growth of the laryngeal cancer treatment market in the future. This refers to the substantial financial burden associated with diagnosing and treating cancer. The elevated costs impact patients financially, contribute to increased healthcare expenses, influence treatment decisions, and negatively affect overall financial well-being. For instance, according to the American Cancer Society Cancer Action Network's (ACS CAN) data from December 2022, survivors' expenses, including follow-up care costs and addressing late and long-term effects of cancer, amounted to $1,881 per survivor. Additionally, 51% of surveyed patients reported incurring medical debt related to cancer, highlighting the challenges posed by the high cost of cancer treatment.

Prominent companies in the laryngeal cancer treatment market are focusing on developing innovative technologies such as Zeno AI to expand their customer base, drive sales, and increase revenue. Zeno AI represents a real-time AI solution designed for cancer detection and classification in the Ear, Nose, and Throat (ENT) region. For example, WSK Medical B.V., a Netherlands-based AI software company, introduced Zeno AI in September 2022. This real-time AI solution facilitates early detection of throat cancer during endoscopic examinations, providing instant localization and classification of laryngeal lesions on endoscopic videos. Zeno AI aims to streamline the early detection and diagnosis of laryngeal cancer, reducing analysis time and enabling faster implementation of care plans.

In November 2021, Coloplast A/S, a Denmark-based medical device manufacturing company, acquired Atos Medical AB for $2.49 billion. This strategic move enhances Coloplast A/S's production capabilities in the tracheostomy and laryngectomy segments, allowing them to establish a global footprint by operating Atos Medical as a separate strategic unit and brand. Atos Medical AB, based in Sweden, specializes in providing innovative laryngectomy and tracheostomy care products.

Major companies operating in the laryngeal cancer therapeutics market report are Pfizer Inc., F. Hoffmann La Roche Ltd., Merck & Co., AbbVie Inc., Novartis AG , Bayer AG, Sanofi-Aventis LLC , Bristol Myers Squibb, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., C.H. Boehringer Sohn AG & Co. KG., Regeneron Pharmaceuticals Inc., Incyte Corporation, Aurobindo Pharma Ltd., Cipla Inc., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals LLC, Lupin Limited , Seagen Inc., Exelixis Pharmaceuticals Inc., BeiGene Ltd., Taiho Pharmaceutical Co. Ltd., Genentech Inc., Mirati Therapeutics Inc.

North America was the largest region in the laryngeal cancer therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the laryngeal cancer therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the laryngeal cancer therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The laryngeal cancer therapeutics market consists of revenues earned by entities by providing services such as diagnostic services, treatment planning and coordination, surgical interventions, radiation therapy, and chemotherapy administration. The market value includes the value of related goods sold by the service provider or included within the service offering. The laryngeal cancer therapeutics market includes sales of radiation therapy machines, targeted therapies, immunotherapy drugs, surgical instruments, and voice prostheses. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Laryngeal Cancer Therapeutics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on laryngeal cancer therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for laryngeal cancer therapeutics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The laryngeal cancer therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Treatment Type: Chemotherapy; Immunotherapy; Other Treatments
• 2) By Route Of Administration: Oral; Parenteral
• 3) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
• 4) By End-User: Hospitals; Homecare; Specialty Centers; Other End-Users
• Companies Mentioned: Pfizer Inc.; F. Hoffmann La Roche Ltd.; Merck & Co.; AbbVie Inc.; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Laryngeal Cancer Therapeutics Market Characteristics

3. Laryngeal Cancer Therapeutics Market Trends And Strategies

4. Laryngeal Cancer Therapeutics Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Laryngeal Cancer Therapeutics Market Size and Growth

• 5.1. Global Laryngeal Cancer Therapeutics Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Laryngeal Cancer Therapeutics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Laryngeal Cancer Therapeutics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Laryngeal Cancer Therapeutics Market Segmentation

• 6.1. Global Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Chemotherapy
• Immunotherapy
• Other Treatments
• 6.2. Global Laryngeal Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oral
• Parenteral
• 6.3. Global Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
• 6.4. Global Laryngeal Cancer Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Homecare
• Speciality Centres
• Other End-Users

7. Laryngeal Cancer Therapeutics Market Regional And Country Analysis

• 7.1. Global Laryngeal Cancer Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Laryngeal Cancer Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Laryngeal Cancer Therapeutics Market

• 8.1. Asia-Pacific Laryngeal Cancer Therapeutics Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Laryngeal Cancer Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Laryngeal Cancer Therapeutics Market

• 9.1. China Laryngeal Cancer Therapeutics Market Overview
• 9.2. China Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Laryngeal Cancer Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Laryngeal Cancer Therapeutics Market

• 10.1. India Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Laryngeal Cancer Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Laryngeal Cancer Therapeutics Market

• 11.1. Japan Laryngeal Cancer Therapeutics Market Overview
• 11.2. Japan Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Laryngeal Cancer Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Laryngeal Cancer Therapeutics Market

• 12.1. Australia Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Laryngeal Cancer Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Laryngeal Cancer Therapeutics Market

• 13.1. Indonesia Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Laryngeal Cancer Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Laryngeal Cancer Therapeutics Market

• 14.1. South Korea Laryngeal Cancer Therapeutics Market Overview
• 14.2. South Korea Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Laryngeal Cancer Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Laryngeal Cancer Therapeutics Market

• 15.1. Western Europe Laryngeal Cancer Therapeutics Market Overview
• 15.2. Western Europe Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Laryngeal Cancer Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Laryngeal Cancer Therapeutics Market

• 16.1. UK Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Laryngeal Cancer Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Laryngeal Cancer Therapeutics Market

• 17.1. Germany Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Laryngeal Cancer Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Laryngeal Cancer Therapeutics Market

• 18.5. France Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.6. France Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.7. France Laryngeal Cancer Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Laryngeal Cancer Therapeutics Market

• 19.9. Italy Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.10. Italy Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.11. Italy Laryngeal Cancer Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Laryngeal Cancer Therapeutics Market

• 20.13. Spain Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.14. Spain Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.15. Spain Laryngeal Cancer Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Laryngeal Cancer Therapeutics Market

• 21.1. Eastern Europe Laryngeal Cancer Therapeutics Market Overview
• 21.2. Eastern Europe Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Laryngeal Cancer Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Laryngeal Cancer Therapeutics Market

• 22.1. Russia Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Laryngeal Cancer Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Laryngeal Cancer Therapeutics Market

• 23.1. North America Laryngeal Cancer Therapeutics Market Overview
• 23.2. North America Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Laryngeal Cancer Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Laryngeal Cancer Therapeutics Market

• 24.1. USA Laryngeal Cancer Therapeutics Market Overview
• 24.2. USA Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Laryngeal Cancer Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Laryngeal Cancer Therapeutics Market

• 25.1. Canada Laryngeal Cancer Therapeutics Market Overview
• 25.2. Canada Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Laryngeal Cancer Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Laryngeal Cancer Therapeutics Market

• 26.1. South America Laryngeal Cancer Therapeutics Market Overview
• 26.2. South America Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Laryngeal Cancer Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Laryngeal Cancer Therapeutics Market

• 27.1. Brazil Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Laryngeal Cancer Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Laryngeal Cancer Therapeutics Market

• 28.1. Middle East Laryngeal Cancer Therapeutics Market Overview
• 28.2. Middle East Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Laryngeal Cancer Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Laryngeal Cancer Therapeutics Market

• 29.1. Africa Laryngeal Cancer Therapeutics Market Overview
• 29.2. Africa Laryngeal Cancer Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Laryngeal Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Laryngeal Cancer Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Laryngeal Cancer Therapeutics Market Competitive Landscape And Company Profiles

• 30.1. Laryngeal Cancer Therapeutics Market Competitive Landscape
• 30.2. Laryngeal Cancer Therapeutics Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. F. Hoffmann La Roche Ltd.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Merck & Co.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. AbbVie Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Novartis AG
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Laryngeal Cancer Therapeutics Market Other Major And Innovative Companies

• 31.1. Bayer AG
• 31.2. Sanofi-Aventis LLC
• 31.3. Bristol Myers Squibb
• 31.4. AstraZeneca plc
• 31.5. Abbott Laboratories
• 31.6. GlaxoSmithKline plc
• 31.7. Eli Lilly and Company
• 31.8. Amgen Inc.
• 31.9. C.H. Boehringer Sohn AG & Co. KG.
• 31.10. Regeneron Pharmaceuticals Inc.
• 31.11. Incyte Corporation
• 31.12. Aurobindo Pharma Ltd.
• 31.13. Cipla Inc.
• 31.14. Hikma Pharmaceuticals plc
• 31.15. Amneal Pharmaceuticals LLC

32. Global Laryngeal Cancer Therapeutics Market Competitive Benchmarking

33. Global Laryngeal Cancer Therapeutics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Laryngeal Cancer Therapeutics Market

35. Laryngeal Cancer Therapeutics Market Future Outlook and Potential Analysis

• 35.1 Laryngeal Cancer Therapeutics Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Laryngeal Cancer Therapeutics Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Laryngeal Cancer Therapeutics Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer